High mobility group box 1 and angiogenetic growth factor levels in children with central nerve system infections

J Infect Chemother. 2021 Jun;27(6):840-844. doi: 10.1016/j.jiac.2021.01.019. Epub 2021 Feb 11.

Abstract

Introduction: To clarify the pathology of children with acute encephalopathy and other neurological disorders, the involvement of high-mobility group box 1 (HMGB1), which is a representative of danger-associated molecular patterns, and angiogenesis-related growth factors were investigated.

Patients and methods: Participants were 12 children with acute encephalopathy (influenza, rotavirus, and others), 7 with bacterial meningitis, and 6 with epilepsy disease (West syndrome). Twenty-four patients with non-central nervous system (CNS) infections as a control group were admitted to our hospital. We examined the levels of HMGB1, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and other cytokines in the serum and cerebrospinal fluid (CSF) of the subjects.

Results: Serum and CSF HMGB1 levels were significantly higher in the encephalopathy and meningitis groups than in the West syndrome and control groups. CSF HMGB1 levels correlated with those of interleukin-6 and -8. CSF HMGB1 and VEGF levels were correlated, and PDGF showed a positive relationship.

Conclusion: HMGB1 and angiogenesis-related growth factors appear to play pivotal roles in the pathophysiology of CNS infections.

Keywords: Encephalopathy; HMGB1; PDGF; Pediatrics; VEGF.

MeSH terms

  • Brain Diseases*
  • Central Nervous System Infections*
  • Child
  • HMGB1 Protein / blood
  • HMGB1 Protein / cerebrospinal fluid
  • HMGB1 Protein / metabolism*
  • Humans
  • Influenza, Human*
  • Vascular Endothelial Growth Factor A

Substances

  • HMGB1 Protein
  • HMGB1 protein, human
  • Vascular Endothelial Growth Factor A